Collagen Solutions (COS)

 

Latest News

Collagen confirms ChondroMimetic deal

Collagen Solutions has announced its first partnering deal for ChondroMimetic with a South Korean partner, Insung Med...

ChondroMimetic? Update

RNS Number: 9488Z Collagen Solutions PLC 20 December 2017 Collagen Solutions Plc (the "Company") ChondroMimetic Update First Partner Deal Agreed with South Korean Partner Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen and tissue components for use in regenerative medicine applications including orthopaed...

Hardman Research: Targeting long-term growth

RNS Number: 8387Z Collagen Solutions PLC 19 December 2017 Hardman Research: Targeting long-term growth Targeting long-term sustainable growth - Collagen Solutions is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, research, and regenerative medicine. A number of investment initiatives...

Collagen Solutions strengthens its board

Collagen Solutions has appointed Chris Brinsmead as a non-executive director. Brinsmead has worked in the pharmaceutic...

All News

DateHeadlineSource
20-12-17Collagen confirms ChondroMimetic dealStockMarketWire
20-12-17ChondroMimetic? UpdateRNS
19-12-17Hardman Research: Targeting long-term growthRNS
18-12-17Collagen Solutions strengthens its board StockMarketWire
18-12-17Directorate ChangeRNS
14-12-17Collagen Solutions appoints CFOStockMarketWire
14-12-17Appointment of Chief Financial OfficerRNS
05-12-17Collagen Solutions H1 losses widen StockMarketWire
05-12-17Half-year ReportRNS
27-11-17Second Price Monitoring ExtnRNS
27-11-17Price Monitoring ExtensionRNS
26-10-17Collagen Solutions first half revenues slip StockMarketWire
26-10-17Trading update and notice of resultsRNS
21-09-17Hardman Research: Engineering towards CE MarkRNS
21-09-17Study Update Patient Assessments CompletedRNS
18-09-17Collagen Solutions to present at Hardman forum StockMarketWire
18-09-17Presenting at the Hardman Investor ForumRNS
12-09-17Issue of EquityRNS
30-08-17Collagen shareholders pass all resolutions at AGMStockMarketWire
30-08-17Result of AGMRNS
30-08-17Collagen Solutions sees progress on key initiatives StockMarketWire
30-08-17AGM StatementRNS
26-07-17Posting of Annual Report & notice of AGMRNS
25-07-17Director Deals - Collagen Solutions Plc (COS)StockMarketWire
25-07-17Director/PDMR ShareholdingRNS
25-07-17Hardman Research: Transition to sustainable growthRNS
13-07-17Director/PDMR ShareholdingRNS
11-07-17Collagen Solutions revenues upStockMarketWire
11-07-17Final ResultsRNS
07-07-17Collagen Solutions starts extension study StockMarketWire
07-07-17First patient enrolment in ChondroMimetic? studyRNS
19-06-17Collagen Solutions schedules FY results StockMarketWire
19-06-17Notice of ResultsRNS
13-06-17Provisional patent submittedRNS
11-05-17Hardman Research: Trading:earnings above forecastsRNS
25-04-17Collagen Solutions revenues upStockMarketWire
25-04-17Trading UpdateRNS
24-04-17Collagen Solutions to consolidate US R&D activities StockMarketWire
24-04-17Consolidation of US R&D activities & Board changeRNS
10-04-17Collagen Solutions presents poster at SFB meeting StockMarketWire

RSS feeds

  • Editorial news feed for LSE:COS Editorial
  • Regulatory news feed for LSE:COS Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account